课题基金 / 基金详情

Change of characterization of human prostate cancer cells to neuronal cells by differentiation induction.

Change of characterization of human prostate cancer cells to neuronal cells by differentiation induction.
通过分化诱导将人前列腺癌细胞的特征改变为神经元细胞。
批准号:
10672060
负责人:
TAKEDA Ken
金额:
$1.79万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

TAKEDA Ken的其他基金

相似基金

相关文献

中文摘要
翻译
我们已经尝试建立一种新的前列腺癌治疗方法,通过控制肿瘤细胞的恶性循环,通过体外终端细胞差异的定义。对人类前列腺癌细胞线差异定义的各种试剂的影响(LNCaP,TSU-Pr 1)进行了审查。Combination of prostaglandin E-D22-D2 and papaverine effectively induces differentiation of LNCaP cells to the cells with partly neuronal?teristics。Phorbol ester,12-O-四-十二烷基phorbol-13-acetate(TPA),TSU-Pr 1细胞的差异化与微胶质细胞的特征学有关。对这些受体的治疗导致了在软琼脂上的退化和对基质的感染性活动的抑制。这些结果建议降低了该地区LNCaP和TSU-Pr 1细胞的恶性循环。我们下一次对不同基因表达的研究性改变,在受诱导的差异化过程中。肿瘤素的表达,如C-myc和Bcl-2在这些不同的细胞中受到了抑制。TPA治疗诱导TSU-Pr 1细胞中CDK抑制剂p21蛋白表达。我们还发现,该指数是通过PKC和MAPK信号通路介导的。Moreover,我们已经确定了一些基因,其中TSU-Pr 1细胞在使用不同显示技术时表现出了不同的诱导差异。在这项研究中,我们展示了人类前列腺癌细胞可以通过治疗与适当的试剂盒一起被诱导的差异化来抑制残疾。我们还建议,对不同基因表达的改变与受诱导的差异有关。
英文摘要
We have been attempting to establish a new method of prostate cancer therapy by controlling the malignancy of tumor cells through the induction of terminal cell differentiation in vitro. The effects of various reagents on the induction of differentiation of the human prostate cancer cell lines (LNCaP, TSU-Pr1) were examined. Combination of prostaglandin EィイD22ィエD2 and papaverine effectively induces differentiation of LNCaP cells to the cells with partly neuronal characteristics. The phorbol ester, 12-O-tetra-decanoylphorbol-13-acetate (TPA), induces differentiation of TSU-Pr1 cells into the cells with characteristics of microglia. Treatment with these reagents caused decrease in colony formation on soft agar and suppression of invasive activity against matrigel. These results suggest that the regents reduced the malignancy of LNCaP and TSU-Pr1 cells. We next investigated alteration of expression of various genes during the induced differentiation. The expression of oncogenes such as c-myc and Bcl-2 was suppressed in these differentiated cells. Treatment with TPA induced the expression of CDK inhibitor p21 protein in TSU-Pr1 cells. We also detected that the induction is mediated through PKC and MAPK signal pathway. Moreover, we identified some genes that are differentially expressed during induced differentiation of TSU-Pr1 cells using differential display technique. In this study, we showed that human prostate cancer cells can be induced differentiation accompanied with decrease of malignancy by treatment with appropriate reagents. We also suggested that the alteration of expression of various genes is associated with the induced differentiation.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
TAKAHISA SHIMIZU: "Papaverine Combind with Prostaglandin E_2 Synergistically Induces Nearon-Like Murphological Chanyes and Decrease of Malignanoy in Human Prostatic Conca LNCaP cells"ANTICANCER RESEARCH. (in press).
TAKAHISA SHIMIZU:“罂粟碱与前列腺素 E_2 结合可协同诱导人前列腺 Conca LNCaP 细胞中的近乎样细胞形态学和减少恶性肿瘤”抗癌研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tomohiro Itayasu, Takahisa Shimizu, Tatsuo Iizumi, Shigeru Oshio, Takashi Umeda and Ken Takeda: "Phrbol ester induces differentiation of a human prostatic cancer cell line TSU-Pr1 into cells with characteristics of Microglia."Anticancer Research. Vol.18.
Tomohiro Itayasu、Takahisa Shimizu、Tatsuo Iizumi、Shigeru Oshio、Takashi Umeda 和 Ken Takeda:“Phrbol 酯诱导人前列腺癌细胞系 TSU-Pr1 分化为具有小胶质细胞特征的细胞。”抗癌研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
TOMOHIRO ITAYASU: "Phorbol Ester Indnces Differentiation of a Human Prostatic Cancer Cell Line TSU-Pr1 into Cells with Characteristics of Microglia"ANTICANCER RESEARCH. 18. 113-118 (1998)
TOMOHIRO ITAYASU:“佛波酯诱导人前列腺癌细胞系 TSU-Pr1 分化为具有小胶质细胞特征的细胞”抗癌研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takahisa Shimizu, Yasuyuki Ohta, Hideyuki Ozawa, Hisashi Matsushima and Ken Takeda: "Papaverine combined with prostaglandin E2 synergistically induces neuron-like morphological changes and decrease of malignancy in human prostatic cancer LNCaP cells."Anti
Takahisa Shimizu、Yasuyuki Ohta、Hideyuki Ozawa、Hisashi Matsushima 和 Ken Takeda:“罂粟碱与前列腺素 E2 联合可协同诱导人前列腺癌 LNCaP 细胞的神经元样形态变化并降低恶性程度。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 8 条
    Antitumor Effect of Zoledronic Acid-Loaded Phosphorylated Pullulan on Bone Metastasis Model of Mice.
    • 批准号:
      24791548
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.75万
    • 财政年份:
      2012
    • 负责人:
      TAKEDA Ken
    • 依托单位:
    Health effect of ionized particle from air purifier on the next generation
    • 批准号:
      23659361
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      TAKEDA Ken
    • 依托单位:
    Research on Structural Change of Supply Chain by Physical Distribution Innovation
    • 批准号:
      21653035
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $1.38万
    • 财政年份:
      2009
    • 负责人:
      TAKEDA Ken
    • 依托单位:
    Effects of nanomaterial exposure on cranial nerve system of offspring
    • 批准号:
      21390037
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.9万
    • 财政年份:
      2009
    • 负责人:
      TAKEDA Ken
    • 依托单位:
    国内基金
    海外基金
    Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
    • 批准号:
      82370979
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      张善勇
    • 依托单位:
    BRD4通过结合TEAD1调控β细胞增殖分化的机制研究
    • 批准号:
      82370801
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      李峰
    • 依托单位:
    22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
    • 批准号:
      82370906
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      代杰文
    • 依托单位:
    新生儿坏死性小肠结肠炎中去泛素化酶USP15调控ILC3分化损伤肠道粘膜屏障的致病机制研究
    • 批准号:
      82371711
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      吕志宝
    • 依托单位: